We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.22B
AUM Growth
+$2.7B
Cap. Flow
+$3.76B
Cap. Flow %
89.24%
Top 10 Hldgs %
40.53%
Holding
623
New
593
Increased
5
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$211M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$189M
3
UNVR
Univar Solutions Inc.
UNVR
+$175M
4
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$143M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$137M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$196M
2
SGFY
Signify Health, Inc.
SGFY
+$161M
3
ONEM
1Life Healthcare
ONEM
+$141M
4
TGNA
TEGNA Inc
TGNA
+$46.6M

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.36%
3 Technology 18.59%
4 Industrials 5.57%
5 Real Estate 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTH icon
201
Meritage Homes
MTH
$4.71B
$2.74M 0.07%
+47,006
New +$2.53M
VSAC
202
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
$2.74M 0.06%
+259,942
New +$2.71M
HR icon
203
Healthcare Realty
HR
$6.92B
$2.69M 0.06%
+138,944
New +$2.8M
XPEV icon
204
XPeng
XPEV
$11.2B
$2.68M 0.06%
+241,364
New +$2.33M
HALO icon
205
Halozyme
HALO
$10.2B
$2.67M 0.06%
+69,920
New +$3.28M
PTCT icon
206
PTC Therapeutics
PTCT
$5.91B
$2.65M 0.06%
+54,763
New +$2.5M
GKOS icon
207
Glaukos
GKOS
$10.1B
$2.64M 0.06%
+52,738
New +$2.56M
NFNT
208
DELISTED
Infinite Acquisition Corp.
NFNT
$2.64M 0.06%
+253,101
New +$2.62M
SWTX
209
DELISTED
SpringWorks Therapeutics
SWTX
$2.56M 0.06%
+99,580
New +$2.91M
TSM icon
210
TSMC
TSM
$2.17T
$2.56M 0.06%
+27,547
New +$2.47M
GOGN
211
DELISTED
GoGreen Investments Corporation
GOGN
$2.52M 0.06%
+238,548
New +$2.5M
ABBV icon
212
AbbVie
ABBV
$431B
$2.52M 0.06%
+15,782
New +$2.41M
ANAB icon
213
AnaptysBio
ANAB
$1.62B
$2.51M 0.06%
+115,479
New +$2.81M
DSAQ
214
DELISTED
Direct Selling Acquisition Corp.
DSAQ
$2.5M 0.06%
+238,161
New +$2.48M
PTGX icon
215
Protagonist Therapeutics
PTGX
$9.46B
$2.49M 0.06%
+108,473
New +$1.82M
FEXD
216
DELISTED
Fintech Ecosystem Development Corp. Class A Common Stock
FEXD
$2.49M 0.06%
+236,311
New +$2.46M
RCFA
217
DELISTED
Perception Capital Corp. IV
RCFA
$2.47M 0.06%
+236,311
New +$2.45M
GTAC
218
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
$2.47M 0.06%
+236,311
New +$2.45M
SZZL
219
DELISTED
Sizzle Acquisition Corp. Common stock
SZZL
$2.47M 0.06%
+236,311
New +$2.45M
CCTS
220
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
$2.47M 0.06%
+236,311
New +$2.45M
AVAC
221
DELISTED
Avalon Acquisition Inc. Class A Common Stock
AVAC
$2.46M 0.06%
+236,311
New +$2.45M
MSAI icon
222
MultiSensor AI
MSAI
$10.3M
$2.46M 0.06%
+5,908
New +$2.44M
APMI
223
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
$2.46M 0.06%
+236,311
New +$2.37M
MRT icon
224
Marti Technologies
MRT
$154M
$2.46M 0.06%
+236,311
New +$2.44M
AXGN icon
225
Axogen
AXGN
$2.38B
$2.45M 0.06%
+259,214
New +$2.37M
7 8
9
10 11

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 623 positions worth $4.22B, up 177% from $1.52B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor deployed $3.76B of net new capital in Q1 2023, opening 593 new positions and adding to 5 existing holdings. Its largest new stake was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Activision Blizzard, an estimated $196M trimmed.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited Signify Health, Inc. in Q1 2023, selling an estimated $161M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 593 new positions and closed 3 in Q1 2023.
  • UBS O'Connor's portfolio value rose 177% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.